Orange Book product · Generic (ANDA)
CHOLESTYRAMINE LIGHT
CHOLESTYRAMINE
At a glance
Oct 31, 2024
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Oct 31, 2024
1 yr 8 mo ago
Today
Pharmaceutical detail
Active ingredient
CHOLESTYRAMINE
Strength
EQ 4GM RESIN/SCOOPFUL
Dosage form
POWDER
Route
ORAL
TE code
Not listed
Application
ANDA 209109
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of CHOLESTYRAMINE
- 1988QUESTRAN LIGHTBrand (NDA)
NDA 019669 · BRISTOL MYERS
- —QUESTRANBrand (NDA)
NDA 016640 · BRISTOL MYERS
- 2026CHOLESTYRAMINEGeneric (ANDA)
ANDA 219318 · MICRO LABS
- 2024CHOLESTYRAMINEGeneric (ANDA)
ANDA 207294 · MACLEODS PHARMS LTD
- 2022CHOLESTYRAMINEGeneric (ANDA)
ANDA 214877 · AIPING PHARM INC
- 2021CHOLESTYRAMINEGeneric (ANDA)
ANDA 211856 · ALKEM LABS LTD
- 2021CHOLESTYRAMINE LIGHTGeneric (ANDA)
ANDA 211799 · ALKEM LABS LTD
- 2021CHOLESTYRAMINEGeneric (ANDA)
ANDA 209597 · PHARMOBEDIENT
- 2020CHOLESTYRAMINE LIGHTGeneric (ANDA)
ANDA 209599 · PHARMOBEDIENT CNSLTG
- 2020CHOLESTYRAMINEGeneric (ANDA)
ANDA 211119 · AJANTA PHARMA LTD
- 2018CHOLESTYRAMINEGeneric (ANDA)
ANDA 202901 · ZYDUS PHARMS
- 2017CHOLESTYRAMINE LIGHTGeneric (ANDA)
ANDA 202902 · ZYDUS PHARMS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
